{"id":21797,"date":"2022-06-09T08:00:23","date_gmt":"2022-06-09T08:00:23","guid":{"rendered":"https:\/\/zeepedia.com\/?p=21797"},"modified":"2022-06-09T11:33:56","modified_gmt":"2022-06-09T11:33:56","slug":"refacto-af","status":"publish","type":"post","link":"https:\/\/zeepedia.com\/medical\/medicines\/refacto-af\/","title":{"rendered":"ReFacto AF | Moroctocog alfa ( recombinant human coagulation factor VIII) uses, dose and side effects"},"content":{"rendered":"\n<p>250 IU, 500 IU, 1000 IU, 2000 IU&nbsp;powder and solvent for solution for&nbsp;injection&nbsp;moroctocog<br>alfa (&nbsp;recombinant&nbsp;human&nbsp;coagulation factor&nbsp;VIII)<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What ReFacto AF is and what it is used for<\/h2>\n\n\n\n<p>ReFacto AF contains the active substance moroctocog alfa,\u00a0human\u00a0coagulation factor\u00a0VIII.\u00a0Factor VIII\u00a0is necessary for your blood to coagulate and stop bleeding.\u00a0In patients with\u00a0hemophilia\u00a0A (congenital\u00a0factor VIII deficiency),\u00a0factor\u00a0VIII is missing or not working\u00a0properly.<\/p>\n\n\n\n<p>ReFacto AF is used to treat and prevent bleeding (\u00a0prophylaxis\u00a0) in adults and children of all ages (including newborns) with\u00a0hemophilia\u00a0A.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What you need to know before using ReFacto AF<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Do not use ReFacto AF<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>if you are allergic to moroctocog alfa or any of the other ingredients of this medicine (listed in section 6).<\/li><li>if you are allergic to\u00a0protein\u00a0you are from hamsters.<\/li><\/ul>\n\n\n\n<p>If you have any further questions, ask your doctor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Warnings and cautions<\/h2>\n\n\n\n<p>Talk to your doctor or pharmacist before using ReFacto AF<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>if you get allergic reactions.\u00a0Signs of allergic reactions include difficulty breathing, shortness of breath, swelling, hives,\u00a0itching, tightness in the chest, wheezing, and low\u00a0blood pressure.\u00a0Anaphylaxis\u00a0is a severe\u00a0allergic reaction\u00a0that can make it difficult to swallow and\/or breathe, and make you red or swollen on the face and\/or hands.\u00a0If you get any of these signs, stop the\u00a0infusion\u00a0immediately and contact a doctor or go to the emergency department immediately.\u00a0In case of severe allergic reactions, an alternative treatment must be considered.<\/li><li>The development of inhibitors (\u00a0antibodies\u00a0) is a known complication that can occur during treatment with any\u00a0factor VIII\u00a0drug.\u00a0The inhibitors prevent, especially at high levels, that the treatment works properly.\u00a0You or your child will be closely monitored for the development of such inhibitors.\u00a0If you or your child suffer from bleeding that cannot be controlled with ReFacto AF, tell your doctor immediately.<\/li><li>if your bleeding does not stop as expected, contact a doctor or seek emergency care immediately.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Other medicines and ReFacto AF<\/h2>\n\n\n\n<p>Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pregnancy, breastfeeding, and fertility<\/h2>\n\n\n\n<p>If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Driving and using machines<\/h2>\n\n\n\n<p>ReFacto AF does not influence the ability to drive or use machines.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">ReFacto AF contains sodium<\/h2>\n\n\n\n<p>After reconstitution,&nbsp;ReFacto&nbsp;AF contains 1.27 mmol (or 29 mg)&nbsp;sodium&nbsp;(the main ingredient in table salt \/ table salt) per&nbsp;vial&nbsp;.&nbsp;This corresponds to 1.5% of the maximum recommended daily intake of&nbsp;sodium&nbsp;for adults.&nbsp;Depending on your body weight and your&nbsp;dose&nbsp;of ReFacto AF, you may receive several vials.&nbsp;This should be considered if you have been prescribed a low-salt diet.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How to use ReFacto AF<\/h2>\n\n\n\n<p>Always take this medicine exactly as your doctor has told you.&nbsp;Ask your doctor or pharmacist if you are unsure.<\/p>\n\n\n\n<p>Treatment with ReFacto AF should be initiated by a doctor who has experience in caring for patients with\u00a0hemophilia\u00a0A. Your doctor will decide what\u00a0dose\u00a0of ReFacto AF you should have.\u00a0The dose\u00a0and duration of treatment depend on your individual need for\u00a0factor VIII\u00a0replacement therapy.\u00a0ReFacto AF is given by\u00a0injection\u00a0into a vein lasting several minutes.\u00a0The patient or their carer can give the\u00a0injections\u00a0with ReFacto AF, provided they have received appropriate training in this.<\/p>\n\n\n\n<p>Your doctor may change the&nbsp;dose&nbsp;of ReFacto AF during treatment.<\/p>\n\n\n\n<p>Consult healthcare professionals before making a trip.&nbsp;You should bring enough&nbsp;factor VIII&nbsp;product with you for expected treatment when you travel.<\/p>\n\n\n\n<p>Each time you use ReFacto AF you should note the name of the carton and the product batch number.\u00a0You can use one of the removable labels on the vial to document the batch number in your diary or to report any\u00a0side effects.<\/p>\n\n\n\n<p><strong>Preparation&nbsp;and&nbsp;administration<\/strong><\/p>\n\n\n\n<p>The instructions below are guidelines for\u00a0the preparation\u00a0and\u00a0administration\u00a0of ReFacto AF.\u00a0Follow your doctor&#8217;s instructions for\u00a0the preparation\u00a0and\u00a0administration\u00a0of ReFacto AF.<\/p>\n\n\n\n<p>Use only the pre-filled syringe in the package for\u00a0reconstitution.\u00a0Other sterile disposable syringes may be used for\u00a0administration.<\/p>\n\n\n\n<p>ReFacto AF is given as an\u00a0intravenous\u00a0infusion\u00a0after\u00a0reconstitution\u00a0of the lyophilized powder for\u00a0injection\u00a0with the supplied syringe of solvent [sodium chloride 9 mg\/ml (0.9%) solution].\u00a0ReFacto AF must not be mixed with other infusion fluids.<\/p>\n\n\n\n<p>Always wash your hands before performing the\u00a0preparation\u00a0and\u00a0administration\u00a0below.\u00a0The aseptic technique (ie clean and germ-free) should be used during\u00a0reconstitution.<\/p>\n\n\n\n<p><em>Preparation:<\/em><\/p>\n\n\n\n<p>Allow the vial of ReFacto AF powder and the pre-filled solvent syringe to reach room temperature.<\/p>\n\n\n\n<p>2. Remove the plastic cap from the ReFacto AF bottle so that the middle part of the rubber stopper is visible.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/05c3eb1f-abdc-4d55-ba52-cb0bda9e17f2\" alt=\"Remove the plastic cap\" title=\"Remove the plastic cap\"\/><\/a><\/figure>\n\n\n\n<p>3. Clean the stopper with the supplied alcohol swab or use another&nbsp;antiseptic&nbsp;solution and allow it to dry.&nbsp;Do not allow your hand to touch the stopper after cleaning and do not allow it to come in contact with any surface.<\/p>\n\n\n\n<p>4. Remove the cap from the transparent plastic package of the bottle adapter.&nbsp;Do not remove the adapter from the package.<\/p>\n\n\n\n<p>5. Place the bottle on a flat surface.&nbsp;Hold the adapter package and place the bottle adapter over the bottle.&nbsp;Press firmly down on the package until the adapter snaps onto the top of the bottle and the adapter needle goes through the rubber stopper of the bottle.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/7a64fea2-b052-4242-bd02-7f829c90846e\" alt=\"Place the bottle adapter\" title=\"Place the bottle adapter\"\/><\/a><\/figure>\n\n\n\n<p>6. Lift the package of the adapter and discard the package.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/4849e94c-e1a9-4a87-b176-87aaf5975c54\" alt=\"Lift the package away from the adapter\" title=\"Lift the package away from the adapter\"\/><\/a><\/figure>\n\n\n\n<p>7. Screw the piston rod onto the solvent syringe by inserting the rod into the opening of the syringe stopper and push and turn the rod firmly until it is securely attached to the stopper.<\/p>\n\n\n\n<p>8. Break the safety plastic cap from the solvent syringe by breaking the perforation on the cap.&nbsp;This is done by bending upwards and downwards until the perforation is broken.&nbsp;Do not touch the inside of the cap or the top of the syringe.&nbsp;The cap may need to be used again (unless the reconstituted ReFacto AF is administered immediately), so set it aside by placing it on top.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/22a611bc-6f11-4288-983a-f0fac0c41448\" alt=\"Break off the safety plastic cap from the syringe\" title=\"Break off the safety plastic cap from the syringe\"\/><\/a><\/figure>\n\n\n\n<p>9. Place the bottle on a flat surface.\u00a0Attach the solvent syringe to the bottle adapter by placing the tip of the syringe in the adapter opening while pressing firmly and screwing the syringe clockwise until it is firmly seated.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/37930d8e-2f34-4345-ae17-1788337a7c92\" alt=\"Attach the solvent syringe to the bottle adapter\" title=\"Attach the solvent syringe to the bottle adapter\"\/><\/a><\/figure>\n\n\n\n<p>10. Slowly push the plunger rod down so that all the solvent is injected into the ReFacto AF bottle.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/15c6e2c8-2e17-46fa-9016-8f97fa7dc795\" alt=\"Slowly push the piston rod down\" title=\"Slowly push the piston rod down\"\/><\/a><\/figure>\n\n\n\n<p>11. Leave the syringe in the adapter and swirl the bottle&nbsp;<strong>gently<\/strong>&nbsp;until the powder has dissolved.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/9af7e32a-6eea-456b-aa23-f6e6cd24c357\" alt=\"Gently swirl the bottle\" title=\"Gently swirl the bottle\"\/><\/a><\/figure>\n\n\n\n<p>12. The finished solution should be inspected visually for particulate matter before\u00a0administration.\u00a0The solution should be ready to be slightly opalescent and colorless.<\/p>\n\n\n\n<p>Note: If you use more than one bottle of ReFacto AF per\u00a0infusion, each bottle should be prepared according to the previous instructions.\u00a0The solvent syringe should be removed, the bottle adapter left in place, and a single large Luer\u00a0syringe\u00a0can be used to withdraw the reconstituted contents from each bottle.<\/p>\n\n\n\n<p>13. Check that the plunger rod of the syringe is still fully depressed and turn the bottle upside down.&nbsp;Slowly pull up all the solution in the syringe through the bottle adapter.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/850d2ec2-efc0-4cc8-a2ad-e28d5141a0b1\" alt=\"Slowly pull up all the solution in the syringe through the bottle adapter\" title=\"Slowly pull up all the solution in the syringe through the bottle adapter\"\/><\/a><\/figure>\n\n\n\n<p>14. Remove the syringe from the bottle adapter by gently pulling and screwing the syringe counterclockwise.&nbsp;Discard the bottle with its fitted adapter.<\/p>\n\n\n\n<p>Note: If the solution is not to be used immediately, the spray cap should be carefully put back in place.&nbsp;Do not bring your fingers to the top of the syringe or the inside of the cap.<\/p>\n\n\n\n<p>ReFacto AF must be used within three hours after\u00a0reconstitution.\u00a0The reconstituted solution can be stored at room temperature before\u00a0administration.<\/p>\n\n\n\n<p><em>Administration&nbsp;(&nbsp;Intravenous&nbsp;infusion&nbsp;):<\/em><\/p>\n\n\n\n<p>ReFacto AF should be administered with the infusion set provided in the kit and the supplied pre-filled syringe with solvent or a single\u00a0sterile\u00a0disposable Luer lock model syringe.<\/p>\n\n\n\n<p>Attach the syringe to the lower end of the infusion set tubing.<\/p>\n\n\n\n<p>Attach a stasis tube and prepare the injection site by wiping the skin well with one of the alcohol compresses in the kit.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/13f6cfa6-7160-4822-958f-8799cd44178f\" alt=\"Prepare the injection site\" title=\"Prepare the injection site\"\/><\/a><\/figure>\n\n\n\n<p>Insert the needle of the infusion line into the vein according to the doctor&#8217;s instructions and remove the stasis tube.&nbsp;Remove air from the infusion set by pulling back on the syringe.&nbsp;The reconstituted product should be injected&nbsp;intravenously&nbsp;over several minutes.&nbsp;Your doctor may change your recommended infusion rate to make your infusion&nbsp;more&nbsp;comfortable.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=19990413000026#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/193f92a3-5751-42ae-91cb-ec961f1053d8\" alt=\"Insert the needle of the infusion set into the vein\" title=\"Insert the needle of the infusion set into the vein\"\/><\/a><\/figure>\n\n\n\n<p>Any unused solution, empty bottle, used needles, and syringes should be discarded in a suitable container for medical waste, as they may harm others if not disposed of properly.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">If you use more ReFacto AF than you should&nbsp;<\/h2>\n\n\n\n<p>Consult a doctor or pharmacist.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">If you stop using ReFacto AF<\/h2>\n\n\n\n<p>Do not stop using ReFacto AF without consulting a doctor.<\/p>\n\n\n\n<p>If you have any further questions on the use of this product, ask your doctor or pharmacist.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Possible side effects<\/h2>\n\n\n\n<p>Like all medicines, this medicine can cause\u00a0side effects, although not everybody gets them.<\/p>\n\n\n\n<p><strong>Allergic reactions<\/strong><\/p>\n\n\n\n<p>If\u00a0<strong>severe, sudden allergic reactions<\/strong>\u00a0(anaphylactic) occur, the\u00a0infusion\u00a0must\u00a0be stopped <strong>immediately.\u00a0<\/strong>You\u00a0<strong>must contact a doctor immediately<\/strong>\u00a0if you get any of the following early symptoms of an allergic reaction:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>rash, hives, general&nbsp;itching<\/li><li>swelling of the lips and tongue<\/li><li>difficulty breathing, wheezing, feeling of tightness in the chest<\/li><li>general malaise<\/li><li>dizziness, unconsciousness<\/li><\/ul>\n\n\n\n<p>Severe symptoms, such as difficulty breathing and (almost) fainting, require immediate medical attention.&nbsp;Severe, sudden allergic reactions (anaphylactic) are less common (may affect up to 1 in 100 people).<\/p>\n\n\n\n<p><strong>Inhibitor development<\/strong><\/p>\n\n\n\n<p>In children who have not been previously treated with\u00a0factor VIII\u00a0drugs, it is very common for inhibitory\u00a0antibodies\u00a0to develop (see section 2) (occurs in more than 1 in 10 patients).\u00a0However, for patients who have previously been treated with\u00a0factor VIII\u00a0(treatment for more than 150 days), the risk is less common (less than 1 in 100 users).\u00a0If you or your child develop\u00a0antibodies, the medicines may stop working properly and you or your child may experience persistent bleeding.\u00a0If this happens, consult a doctor immediately.<\/p>\n\n\n\n<p><strong>Very common&nbsp;side effects&nbsp;(<\/strong>&nbsp;may affect more than 1 user in 10)<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>inhibitor development in patients who have not been previously treated with&nbsp;factor VIII&nbsp;products<\/li><li>headache<\/li><li>cough<\/li><li>joint pain<\/li><li>fever.<\/li><\/ul>\n\n\n\n<p><strong>Common&nbsp;side effects&nbsp;(<\/strong>&nbsp;may affect up to 1 in 10 people)<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>bleeding<\/li><li>dizziness<\/li><li>decreased appetite, diarrhea, vomiting, abdominal pain, nausea<\/li><li>hives, rash,\u00a0itching<\/li><li>muscle pain<\/li><li>chills, reaction at the catheter site<\/li><li>Some blood tests may show an increase in the number of\u00a0antibodies\u00a0to\u00a0factor VIII.<\/li><\/ul>\n\n\n\n<p><strong>Uncommon&nbsp;side effects&nbsp;(<\/strong>&nbsp;may affect up to 1 in 100 people)<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>inhibitor development in patients who have previously been treated with\u00a0factor VIII\u00a0products (less than 1 in 100 users)<\/li><li>severe\u00a0allergic reaction<\/li><li>numbness, drowsiness, altered taste experience<\/li><li>chest pain, fast heart rate, palpitations<\/li><li>low\u00a0blood pressure, pain, and\u00a0redness\u00a0in a vein associated with a blood clot, hot flashes<\/li><li>shortness of breath<\/li><li>heavy sweating<\/li><li>weakness, injection site reactions including pain<\/li><li>slight increase in cardiac enzymes<\/li><li>increased liver enzyme values increased\u00a0bilirubin.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">How to store ReFacto AF<\/h2>\n\n\n\n<p>Keep this medicine out of the sight and reach of children.<\/p>\n\n\n\n<p>Do not use this medicine after the expiry date which is stated on the carton and bottle label after EXP.&nbsp;The expiration date is the last day of the specified month.<\/p>\n\n\n\n<p>Store and transport cold (2 \u00b0 C-8 \u00b0 C).&nbsp;Do not freeze (to avoid damaging the pre-filled syringe with solvent).<\/p>\n\n\n\n<p>If necessary, the drug can be taken out of the refrigerator and stored for a continuous period of a maximum of three months at room temperature (maximum 25 \u00b0 C).&nbsp;At the end of the storage period at room temperature, the product must not be put back in the refrigerator but must be used or discarded.&nbsp;Make a note on the outer carton of the date when the ReFacto AF is removed from the refrigerator and stored at room temperature (maximum 25 \u00b0 C).<\/p>\n\n\n\n<p>Keep the vial in the outer carton.&nbsp;Sensitive to light.<\/p>\n\n\n\n<p>Use the reconstituted solution within three hours after\u00a0reconstitution.<\/p>\n\n\n\n<p>The solution should be clear to slightly opalescent and colorless.&nbsp;Do not use this medicine if you notice that it is cloudy or contains visible particles.<\/p>\n\n\n\n<p>Medicines should not be disposed of via wastewater or household waste.&nbsp;Ask your pharmacist how to dispose of medicines no longer required.&nbsp;These measures will help to protect the environment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contents of the pack and other information<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Content declaration<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>The active substance is moroctocog alfa (\u00a0recombinant\u00a0coagulation factor\u00a0VIII).\u00a0One bottle of ReFacto AF nominally contains 250, 500, 1000, or 2000 IU moroctocog alfa.<\/li><li>The other ingredients are sucrose, calcium chloride dihydrate, L-histidine, polysorbate 80, and sodium chloride (see section 2 \u201cReFacto AF contains sodium\u201d).\u00a0A solvent [sodium chloride 9 mg \/ ml (0.9%)\u00a0solution for injection\u00a0] is provided for\u00a0reconstitution\u00a0.<\/li><li>After\u00a0reconstitution\u00a0with the supplied solvent [sodium chloride 9 mg \/ ml (0.9%) solution], one\u00a0vial\u00a0contains 62.5, 125, 250 and 500 IU respectively (based on the potency of moroctocog alfa, ie 250, 500, 1000 or 2000 IU). IU) moroctocog alfa per 1 ml reconstituted\u00a0solution for injection.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What the medicine looks like and the contents of the pack<\/h2>\n\n\n\n<p>ReFacto AF is supplied as a powder for\u00a0injection\u00a0in a glass\u00a0vial\u00a0and a solvent is supplied in a pre-filled\u00a0syringe.\u00a0<\/p>\n\n\n\n<p>The package contains:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>one bottle of moroctocog alfa 250, 500, 1000, or 2000 IU powder<\/li><li>a pre-filled\u00a0syringe\u00a0of solvent, 4 ml\u00a0sterile\u00a0sodium chloride 9 mg\/ml (0.9%)\u00a0solution\u00a0for injection,\u00a0with a plunger rod<\/li><li>a\u00a0sterile\u00a0bottle adapter device for\u00a0reconstitution<\/li><li>a sterile infusion set<\/li><li>two alcohol compresses<\/li><li>a\u00a0patch<\/li><li>a\u00a0compress<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Marketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n<p>Pfizer Europe MA EEIG<\/p>\n\n\n\n<p>Boulevard de la Plaine 17<\/p>\n\n\n\n<p>1050 Brussels<\/p>\n\n\n\n<p>Belgium<\/p>\n\n\n\n<p><strong>Manufacturer<\/strong><\/p>\n\n\n\n<p>Wyeth Farma SA<\/p>\n\n\n\n<p>Autovia del Norte A-1 Km 23<\/p>\n\n\n\n<p>Desvio Algete Km 1<\/p>\n\n\n\n<p>28700 San Sebastian de los Reyes<\/p>\n\n\n\n<p>Madrid<\/p>\n\n\n\n<p>Spain<\/p>\n\n\n\n<p>Contact the representative of the marketing authorization holder to find out more about this medicine:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>Belgium \/ Belgique \/ Belgien<\/strong>Pfizer SA \/ NVTel: +32 (0) 2 554 62 11<\/td><td><strong>Lithuania<\/strong>Pfizer Luxembourg SARL branches in LithuaniaTel.&nbsp;+3705 2514000<\/td><\/tr><tr><td><strong>Bulgaria<\/strong>Pfizer Luxembourg SARE, Clone of BulgariaTel: +359 2 970 4333<\/td><td><strong>Luxembourg \/ Luxemburg<\/strong>Pfizer SATel: +32 (0) 2 554 62 11<\/td><\/tr><tr><td><strong>Czech Republic<\/strong>Pfizer, spol.&nbsp;s roTel: +420 283 004 111<\/td><td><strong>Hungary<\/strong>Pfizer Kft.Tel .: + 36 1 488 37 00<\/td><\/tr><tr><td><strong>Denmark<\/strong>Pfizer ApSTel: +45 44 20 11 00<\/td><td><strong>Malta<\/strong>Vivian Corporation Ltd.Tel: +35621 344610<\/td><\/tr><tr><td><strong>Germany<\/strong>Pfizer Pharma GmbHTel: +49 (0) 30 550055 51000<\/td><td><strong>The Netherlands<\/strong>Pfizer bvTel: +31 (0) 10 406 43 01<\/td><\/tr><tr><td><strong>Eesti<\/strong>Pfizer Luxembourg SARL Eesti subsidiaryTel: +372 666 7500<\/td><td><strong>Norway<\/strong>Pfizer ASTel: +47 67 526 100<\/td><\/tr><tr><td><strong>Greece<\/strong>PFIZER \u0395\u039b\u039b\u0391\u03a3 \u0391.\u0395:\u0397\u03bb: +30 210 678 5800<\/td><td><strong>Austria<\/strong>Pfizer Corporation Austria Ges.mbHTel: +43 (0) 1 521 15-0<\/td><\/tr><tr><td><strong>Spain<\/strong>Pfizer SLTel: +34 91 490 99 00<\/td><td><strong>Poland<\/strong>Pfizer Polska Sp.&nbsp;z oo,Tel .: +48 22 335 61 00<\/td><\/tr><tr><td><strong>France<\/strong>PfizerTel: +33 (0) 1 58 07 34 40<\/td><td><strong>Portugal<\/strong>Pfizer Laboratories, Lda.Tel: +351 21 423 5500<\/td><\/tr><tr><td><strong>Croatia<\/strong>Pfizer Croatia dooTel: +385 1 3908 777<\/td><td><strong>Romania<\/strong>Pfizer Rom\u00e2nia SRLTel: +40 21 207 28 00<\/td><\/tr><tr><td><strong>Ireland<\/strong>Pfizer Healthcare IrelandTel: 1800 633 363 (toll free)+44 (0) 1304 616161<\/td><td><strong>Slovenia<\/strong>Pfizer Luxembourg SARLPfizer, a company in the field of pharmaceuticals, LjubljanaTel: + 386 (0) 1 52 11 400<\/td><\/tr><tr><td><strong>Iceland<\/strong>Icepharma hf.Phone: + 354 540 8000<\/td><td><strong>Slovak Republic<\/strong>Pfizer Luxembourg SARL, organizerTel: + 421-2-3355 5500<\/td><\/tr><tr><td><strong>Italy<\/strong>Pfizer SrlTel: +39 06 33 18 21<\/td><td><strong>Finland \/ Finland<\/strong>Pfizer OyPuh \/ Tel: +358 (0) 9 43 00 40<\/td><\/tr><tr><td><strong>.\u03a0\u03c1\u03bf\u03c2<\/strong>PFIZER \u0395\u039b\u039b\u0391\u03a3 \u0391.\u0395.(CYPRUS BRANCH):\u0397\u03bb: +357 22 817690<\/td><td><strong>Sweden<\/strong>Pfizer ABTel: + 46 (0) 8 550 520 00<\/td><\/tr><tr><td><strong>Latvia<\/strong>Pfizer Luxembourg SARL subsidiary Latvij\u0101Tel: +371 670 35 775<\/td><td><strong>United Kingdom (Northern Ireland)<\/strong>Pfizer LimitedTel: +44 (0) 1304 616161<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>ReFacto AF contains the active substance moroctocog alfa, human coagulation factor VIII. Factor VIII is necessary for your blood to coagulate and stop bleeding. In patients with haemophilia A (congenital factor VIII deficiency), factor VIII is missing or not working properly.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2200,18529],"tags":[22529,22525,22528,22534,22530,22533,22526,22531,22527,22532],"class_list":["post-21797","post","type-post","status-publish","format-standard","hentry","category-medicines","category-r","tag-benefits-of-moroctocog-alfa","tag-moroctocog-alfa","tag-moroctocog-alfa-side-effects","tag-recombinant-human-coagulation-factor-viii","tag-refacto-af","tag-refacto-af-side-effects","tag-what-is-moroctocog-alfa","tag-what-is-refacto-af","tag-what-moroctocog-alfa-is-used-for","tag-what-refacto-af-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/21797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=21797"}],"version-history":[{"count":4,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/21797\/revisions"}],"predecessor-version":[{"id":21826,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/21797\/revisions\/21826"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=21797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=21797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=21797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}